Novel Coronavirus (SARS-CoV-2/COVID-19)
A social worker with the U.S. Army Reserve bonds with a 96-year-old patient, a veteran of World War II now fighting COVID-19.
Dartmouth-Hitchcock Health collaborates with community partners to improve food access during the COVID-19 pandemic.
The Food and Drug Administration authorized the University of California San Francisco’s Clinical Labs at China Basin to use a new molecular-based diagnostic test for SARS-CoV-2.
The Centers for Disease Control and Prevention released guidance for emergency medical planners and health care facilities on identifying relief health care facilities, and establishing or using medical operation coordination cells to improve surge capacity and resource allocation during the COVID-…
The sight of families re-emerging to gather at community playgrounds and pools brings mixed emotions. While it’s gratifying to see people enjoying themselves again, it’s also clear that COVID-19 is not in the rearview mirror, as spiking infection rates in many states demonstrate.
Certain groups of workers showed significantly more absenteeism in March and April 2020, suggesting a link to COVID-19 exposure, according to a new study released today by the Centers for Disease Control and Prevention.
Wear a mask. Wash your hands. Keep your distance. These are three simple actions we know that will stop the spread of COVID-19. The AHA, American Medical Association and the American Nurses Association shared those messages in an open letter to the American public.
Join AHA’s Board Chair Dr. Mindy Estes for Leadership Rounds as she discusses key issues with Dr. Marc Boom, President and CEO, Ella Fondren and Josie Roberts Presidential Distinguished Centennial Chair, Houston Methodist. Watch the live stream at 2:30 p.m. to 2:45 p.m. ET/1:30 p.m. to 1:45 p.m. CT…
The Mount Sinai Health System will partner with Emergent BioSolutions and ImmunoTek Bio Centers on the development and evaluation of a COVID-19 hyperimmune globulin product, it was announced.
Gilead Sciences said it is starting phase one clinical study of inhaled remdesivir for potential outpatient treatment of COVID-19. In a statement, Gilead said the inhaled version could better target respiratory infections and limit systemic exposure to remdesivir and be accessible to non-…